FdaApplication
ANDA 201824
Identifiers
- fda_app_no: ANDA201824
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2015-09-15 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CLOZAPINE | CLOZAPINE | 25MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| CLOZAPINE | CLOZAPINE | 200MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| CLOZAPINE | CLOZAPINE | 100MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| CLOZAPINE | CLOZAPINE | 12.5MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| CLOZAPINE | CLOZAPINE | 150MG | TABLET, ORALLY DISINTEGRATING;ORAL |
5 products